GVR Report cover Self-injection Devices Market Size, Share & Trends Report

Self-injection Devices Market Size, Share & Trends Analysis Report By Product (Autoinjectors, Needle-free Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Pain Management), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-919-4
  • Number of Report Pages: 120
  • Format: PDF, Horizon Databook
  • Historical Range: 2017 - 2020
  • Forecast Period: 2022 - 2030 
  • Industry: Healthcare

Report Overview

The global self-injection devices market size was estimated at USD 6.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2022 to 2030. The rising preference for self-administration of drugs, an increasing number of regulatory approvals, and usability advantages are anticipated to fuel the growth. Government support, favorable reimbursements, and technological advancements in self-injection devices are the major factors anticipated to augment the market growth.

Germany self-injection devices market size, by usability, 2020 - 2030 (USD Million)

The COVID-19 pandemic had a positive impact on the self-injection devices market as the requirement for self-injectable devices and mass vaccination witnessed a rise since the outbreak of the disease. As the number of COVID-19 cases increased across regions, the majority of the market players have invested in R&D activities and have started entering into agreements and partnerships with government organizations and other industry firms to develop self-injection devices for the disease.

The threat of getting exposed to COVID-19 has urged patients, particularly those suffering from chronic ailments to opt for self-administration of medication such as self-injection devices at home for easy use. Healthcare professionals are keeping healthcare properties free for COVID-19 victims and patients with a need for acute care. This has generated the demand for self-injection devices such as wearable injectors. Hence, the COVID-19 pandemic positively impacted market growth.

Needlestick injuries from contaminated needles are the main area of concern for the majority of healthcare providers. Injuries caused due to needle sticks are among the most serious threats. For example, injections are among the most common devices used for drug administration due to which healthcare workers are at a major risk of exposure to blood-borne pathogens that can occur accidentally. Hence, the increase in cases of needlestick injuries is anticipated to propel the demand for self-injection devices during the forecast period.

Self-injection technologies are relatively faster means of delivering drugs and allow improved reproducibility in comparison to invasive drug delivery technologies. These devices minimize the drug dosage requirement that ultimately translates into improved patient compliance, specifically among elder patients. Needle-free injectors such as jet injectors are effective and convenient and feature fewer hospital stays & overall healthcare costs and offer better patient compliance, and are easy to use in-home care settings. Hence, increasing advantages associated with self-injection devices are anticipated to foster overall market growth.

Product Insights

The pen injectors segment held the largest revenue share of around 28% in 2021 due to their high efficiency and adoption rate across the globe. Pen injectors are principally sophisticated syringes and are well developed for accurate and reliable administration of biotech molecules such as human growth hormone and insulin. The development of pen injectors has made administering drugs much more convenient and easier for patients, thereby surging its demand during the forecast period. The number of acute and chronic diseases has been on the rise, leading to rising awareness regarding the importance of pen injectors among patients in emerging countries.

The wearable injectors segment held a significant market share in 2021. Wearable injectors offer benefits such as reduced pain, ease of administration, and minimized difficulty compared to syringes, thereby increasing their market penetration. Cost and difficulties associated with the traditional settings have encouraged patients to opt for cost-effective alternatives, thereby generating demand for wearable injectors. Increasing adoption of wearable injectors among diabetics owing to their competitive advantage over insulin pumps and the increasing R&D investments in wearable injectors are predicted to surge the market progression.

Usability Insights

The disposable segment held the largest revenue share of around 62% in 2021. Rising concerns over the hazards associated with needle stick injuries and rising awareness regarding benefits offered by drug delivery devices have stimulated quick growth in the market for disposable self-injection devices. These devices are convenient for frequent, low-volume injections or variable dosing. Several companies such as BD, Gerresheimer AG, and Ypsomed AG have introduced novel and innovative products to gain a strong market position.

The reusable segment held a considerable market share in 2021. Reusable self-injection devices are majorly recommended by healthcare professionals and doctors to reduce the risk of infections. These devices provide great durability as they are manufactured from precision-engineered and superior materials, that also aid the physicians to reuse several times. However, factors such as costly sterilization procedures and high device prices are some of the factors which are anticipated to hamper segment growth during the forecast period.

Application Insights

Cancer is among the leading segments holding around 27% of the revenue share in 2021. The increasing prevalence of cancer is predicted to surge the demand for self-injection devices during the forecast period. For instance, according to the National Cancer Institute, about 1,806,590 new cancer cases were diagnosed in the U.S. in 2020. The rising shift toward self-administration of medication among cancer patients is expected to foster the growth of the segment. 

Global self-injection devices market share, by application, 2021 (%)

The pain management segment is expected to witness over 6.0% CAGR during the forecast period. The growth of the segment is attributable to the increasing cases of chronic pain and technological advancements. The high prevalence of chronic diseases and the rising geriatric population across the globe are other major factors expected to contribute to the growth of this segment over the forecast period.

Regional Insights

North America dominated the market in 2021 with a revenue share of more than 42%, due to sedentary lifestyle, high cost of treatments, increasing elderly population, and high recurrence rate of autoimmune disorders. Factors such as the rising prevalence of chronic and lifestyle-related diseases and the presence of sophisticated healthcare infrastructure are predicted to accelerate the market growth. In addition, the local presence of major market players in the U.S., such as Becton, Dickinson and Company (BD) and Ypsomed AG is estimated to propel the regional growth.

Europe accounted for the second-highest share of the market based on revenue. It is expected to exhibit a CAGR of around 5.5% during the forecast period. The increasing prevalence of chronic diseases is expected to drive the adoption of self-injection devices among healthcare professionals. The region is expected to witness lucrative growth during the forecast period due to the presence of skilled professionals and well-established healthcare infrastructure.

Asia Pacific is predicted to exhibit a significant CAGR during the forecast period. Large unmet needs with improving healthcare facilities and developing reimbursement policies, especially in countries such as China and India are the factors anticipated to aid the growth of this market. The increasing elderly population and rising incidence of chronic and autoimmune diseases within this region are anticipated to further fuel the growth. Furthermore, increasing healthcare expenditure in China and Japan is expected to boost the demand for self-injection devices during the forecast period.

Key Companies & Market Share Insights

The key market players engage in vital business strategies such as joint ventures, strategic partnerships and collaborations, mergers & acquisitions, new product launches, and product innovation, to build their market positions alongside gaining popularity in the market. The market is competitive as key players are engaged in rigorous R&D activities to develop cost-effective and efficient self-injection devices.

For instance, in October 2021, Ypsomed introduced the world’s first autoinjector with integrated connectivity. It connects the SmartPilot, a networked reusable attachment to the YpsoMate autoinjector for incorporating the auto-injector into a digital therapy management system. Some prominent players in the global self-injection devices market include:

  • Ypsomed AG

  • BD

  • Gerresheimer AG

  • Antares Pharma

  • Haselmeier AG

  • NuGen Medical Devices

  • Owen Mumford Ltd

  • SHL Medical AG

  • Pfizer, Inc.

  • Amgen 

Self-injection Devices Market Report Scope

Report Attribute


Market size value in 2022

USD 6.9 billion

Revenue forecast in 2030

USD 10.8 billion

Growth rate

CAGR of 5.7% from 2022 to 2030

Base year for estimation


Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million & CAGR from 2022 to 2030

Report coverage

Revenue forecast, company share, competitive landscape, growth factors & trends

Segments covered

Product, usability, application, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; South Korea; Australia; Brazil; Mexico; Argentina; Columbia; South Africa; Saudi Arabia; UAE

Key companies profiled

Ypsomed AG; BD; Gerresheimer AG; Antares Pharma; Haselmeier AG; NuGen Medical Devices; Owen Mumford Ltd; SHL Medical AG; Pfizer, Inc.; Amgen

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global self-injection devices market report based on product, usability, application, and region:

  • Product Outlook (Revenue, USD Million, 2017 - 2030)

    • Autoinjectors

    • Pen Injectors

    • Wearable Injectors

    • Needle-free Injectors

  • Usability Outlook (Revenue, USD Million, 2017 - 2030)

    • Disposable

    • Reusable

  • Application Outlook (Revenue, USD Million, 2017 - 2030)

    • Cancer

    • Autoimmune Disorders

    • Hormonal Disorders

    • Pain Management

    • Others

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.